Skip to main content
. 2025 Mar 10;20(2):167–172. doi: 10.30699/ijp.2025.2040168.3350

Table 1.

Demographic and clinical variables. Chi-square was used for categorical and independent T-tests, and the Mann-Whitney test was used for scale variables. Statistical significance is defined as having a p-value less than 0.05.

Characteristic CLDN high (n = 58) CLDN Low (n = 14) P-value
Age at diagnosis, mean year (SD) 54.3(11.6) 58.6(12.7) 0.223
Tumor grade, N (%)
Grade 1 2 (3.4) 2 (14.3) 0.281
Grade 2 15 (25.9) 3 (21.4)
Grade 3 41 (70.7) 9 (64.3)
Disease Stage, N (%) 0.154
1 16 (24.6) 6 (42.9)
2 25 (43.1) 4 (28.6)
3 13 (22.4) 1 (7.1)
4 4 (6.9) 3 (21.4)
Type of surgery received, N (%)
Lumpectomy 39 (67.2) 10 (71.4) 0.517
Mastectomy 19 (32.8) 4 (28.6)
No surgery 0 () 0 ()
lymph node involvement, N (%) 18 (31.0) 4 (28.6) 0.567
Tumor size (cm), N (%)
≤ 2 16 (27.6) 6 (42.9) 0.368
>2 42 (72.4) 8 (57.0)
Cancer history in the family, N (%)
No 30 (51.7) 6 (42.9) 0.587
Breast Cancer 15 (25.9) 3 (21.4)
Other cancers 13 (22.4) 5 (35.7)
Treatment type 0.560
Chemotherapy and radiotherapy 51 (87.9) 12 (85.7)
Chemotherapy 7 (12.1) 2 (14.3)
Ki-67 expression, mean % (±SD) 46.55(±20.2) 42.79(±20.2) 0.617
Disease history, N (%)
No history 37 (63.8) 11 (78.0) 0.234
CVD, hypertension, or diabetes 21 (34.5) 3 (21.4)